In the present study, we use immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect the expression and genetic abnormalities, particularly gene translocation and amplification of C-MYC, BCL-2, and BCL-6 genes in patients with DLBCL. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.